Sun Pharma
Anu Mahashabde is an accomplished professional in the field of regulatory affairs, currently serving as the Global Regulatory Affairs Portfolio Lead at Sun Pharma since February 2025. Prior experience includes significant roles such as the North America Regulatory Affairs Therapeutic Lead for Immunology and Neurology at Sanofi Genzyme from August 2020 to January 2025, and various leadership positions at Pfizer between 2010 and 2020, including Global Regulatory Strategy - Growth Lead and Senior Director of Global Established Pharma Regulatory Strategy. Anu also worked as a Chief Research and Regulatory Consultant at Teva Pharmaceuticals and held the position of Senior Director of Research and Development at Barr Laboratories. Anu's academic credentials include a Ph.D. in Pharmaceutics from Duquesne University, obtained between 1984 and 1989.
This person is not in any teams
This person is not in any offices
Sun Pharma
26 followers
Sun Pharma is the world's fourth largest specialty generic pharmaceutical company and No. 1 in India. We provide high-quality, affordable medicines trusted by customers and patients in over 100 countries. Sun Pharma's global presence is supported by more than 40 manufacturing facilities spread across 5 continents, R&D centres across the globe and a multi-cultural workforce comprising over 50 nationalities. Sun Pharma fosters excellence through innovation supported by strong R&D capabilities comprising around 2,000 scientists and R&D investments of over 7-8% of annual revenues. See our community guideline: bit.ly/3DsQxdK